Simplify Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Simplify Asset Management’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$563K	Buy	153,794 +37,800	+33%	+$230K	0.01%	104
2026 Q1	$890K	Sell	115,994 -43,680	-27%	-$405K	0.01%	80
2025 Q4	$1.81M	Buy	159,674 +76,440	+92%	+$778K	0.03%	68
2025 Q3	$766K	Buy	83,234 +10,080	+14%	+$72.9K	0.01%	89
2025 Q2	$503K	Sell	73,154 -7,980	-10%	-$42.7K	0.03%	75
2025 Q1	$234K	Buy	81,134 +420	+0.5%	+$1.54K	0.01%	91
2024 Q4	$379K	Sell	80,714 -270,600	-77%	-$998K	0.02%	82
2024 Q3	$1.25M	Sell	351,314 -323,518	-48%	-$2.4M	0.06%	66
2024 Q2	$4.18M	Sell	674,832 -1,199	-0.2%	-$9.08K	0.28%	33
2024 Q1	$6.38M	Buy	676,031 +112,706	+20%	+$1.01M	0.38%	19
2023 Q4	$3.8M	Sell	563,325 -7,194	-1%	-$31.9K	0.34%	21
2023 Q3	$2.53M	Sell	570,519 -125,777	-18%	-$550K	0.29%	40
2023 Q2	$2.3M	Buy	696,296 +57,178	+9%	+$168K	0.3%	48
2023 Q1	$1.82M	Buy	+639,118	New	+$5.73M	0.26%	45

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Simplify Asset Management's FULC Position: Q2 2026 in Review

Simplify Asset Management increased its Fulcrum Therapeutics (FULC) stake by 33% in Q2 2026, buying an estimated $230K and bringing the position to 153,794 shares worth $563K. The position accounts for 0.01% of the portfolio, ranked #104.

Simplify Asset Management first reported a position in FULC in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.38M in Q1 2024. 43 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

Simplify Asset Management held 153,794 shares of Fulcrum Therapeutics worth $563K as of Q2 2026.
Simplify Asset Management bought 37,800 Fulcrum Therapeutics shares in Q2 2026, an estimated $230K.
Fulcrum Therapeutics made up 0.01% of Simplify Asset Management's portfolio in Q2 2026, its #104 holding.
Simplify Asset Management first reported a position in Fulcrum Therapeutics in Q1 2023 and has held it in 14 quarters since.
Simplify Asset Management's Fulcrum Therapeutics position peaked at $6.38M in Q1 2024.
43 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.